Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:32225123

Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.

Yu-Li Su · Hao-Lun Luo · Chun-Chieh Huang · Ting-Ting Liu · Eng-Yen Huang · Ming-Tse Sung · Jen-Jie Lin · Po-Hui Chiang · Yen-Ta Chen · Chih-Hsiung Kang · Yuan-Tso Cheng

Cells · 2020 doi:10.3390/cells9040806

Paper

complete

Experiment

complete

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:32225123
kind
science-record
content_hash
sha256:f0c0304aff5d9bed5078909a5c3bd9aafb8e704412eb7d879ccb7e4b06bdd0d2
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:58Z
updated_at
2026-11-01T21:23:03Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.
doi
10.3390/cells9040806
pmid
32225123
authors array · 11 items
[0]
Yu-Li Su
[1]
Hao-Lun Luo
[2]
Chun-Chieh Huang
[3]
Ting-Ting Liu
[4]
Eng-Yen Huang
[5]
Ming-Tse Sung
[6]
Jen-Jie Lin
[7]
Po-Hui Chiang
[8]
Yen-Ta Chen
[9]
Chih-Hsiung Kang
[10]
Yuan-Tso Cheng
journal
Cells
year
2020
abstract
Galectin-1 (GAL1) is a β-galactoside-binding protein involved in multiple aspects of tumorigenesis. However, the biological role of GAL1 in upper tract urothelial carcinoma (UTUC) has not been entirely understood. Herein, we investigated the oncological effects of GAL1 expression in tumor specimens and identified related gene alterations through molecular analysis of GAL1. Clinical parameter data and tumor specimens were collected from 86 patients with pT3N0M0 UTUC who had undergone radical nephroureterectomy. We analyzed the difference in survival by using Kaplan-Meier analyses and Cox proportional regression models and in GAL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the Cancer Genome Atlas (TCGA) and GSE32894 data sets were analyzed for comparison. Using four urothelial carcinoma (UC) cell lines (BFTC-909, T24, RT4, and J82) as in vitro models, we evaluated the functions of GAL1 in UC cell growth, invasiveness, and migration and its role in downstream signaling pathways. The study population was classified into two groups, GAL1-high (n = 35) and GAL1-low (GAL1 n = 51), according to IHC interpretation. Univariate analysis revealed that high GAL1 expression was significantly associated with poor recurrence-free survival (RFS; p = 0.028) and low cancer-specific survival (CSS; p = 0.025). Multivariate analysis revealed that GAL1-high was an independent predictive factor for RFS (hazard ratio (HR) 2.43; 95% confidence interval (CI) 1.17-5.05, p = 0.018) and CSS (HR 4.04; 95% CI 1.25-13.03, p = 0.019). In vitro studies revealed that GAL1 knockdown significantly reduced migration and invasiveness in UTUC (BFTC-909) and bladder cancer cells (T24). GAL1 knockdown significantly reduced protein levels of matrix metalloproteinase-2 (MMP-2) and MMP-9, which increased tissue inhibitor of metalloproteinase-1 (TIMP-1) and promoted epithelial-mesenchymal transition (EMT). Through gene expression microarray analysis of GAL1 vector and GAL1-KD cells, we identified multiple significant signaling pathways including p53, Forkhead box O (FOXO), and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT). We validated microarray results through immunoblotting, thus proving that downregulation of GAL1 reduced focal adhesion kinase (FAK), p-PI3K, p-AKT, and p-mTOR expression. We concluded that GAL1 expression was highly related to oncological survival in patients with locally advanced UTUC. GAL1 promoted UC invasion and metastasis by activating the FAK/PI3K/AKT/mTOR pathway.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Kaplan–Meier analyses and Cox proportional regression models were used for univariate and multivariate survival analyses.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32225123
locator
sections[14] "2.12. Statistical Analysis" paragraph 2
quote
Kaplan–Meier analyses and Cox proportional regression models were used for univariate and multivariate survival analyses.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32225123
locator
sections[13] "2.11. Bioinformatics Analysis" paragraph 2
quote
We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:32225123
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE32894
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE32894
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 5 items
[0] object · 15 fields
id
source:pmid:32225123
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3390/cells9040806
sha256
sha256:6e01640ca0b329a9380c87ac0efde3ca904f3c66844242c2cb268ffc2564046e
bytes
46843
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3390/cells9040806
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7226470
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE32894
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32894
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE32894
version
null
note
We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).
access_statement_kind
repository_route_statement
sample_accessions array · 308 items
[0]
GSM814052
[1]
GSM814053
[2]
GSM814054
[3]
GSM814055
[4]
GSM814056
[5]
GSM814057
[6]
GSM814058
[7]
GSM814059
[8]
GSM814060
[9]
GSM814061
[10]
GSM814062
[11]
GSM814063
[12]
GSM814064
[13]
GSM814065
[14]
GSM814066
[15]
GSM814067
[16]
GSM814068
[17]
GSM814069
[18]
GSM814070
[19]
GSM814071
[20]
GSM814072
[21]
GSM814073
[22]
GSM814074
[23]
GSM814075
[24]
GSM814076
[25]
GSM814077
[26]
GSM814078
[27]
GSM814079
[28]
GSM814080
[29]
GSM814081
[30]
GSM814082
[31]
GSM814083
[32]
GSM814084
[33]
GSM814085
[34]
GSM814086
[35]
GSM814087
[36]
GSM814088
[37]
GSM814089
[38]
GSM814090
[39]
GSM814091
[40]
GSM814092
[41]
GSM814093
[42]
GSM814094
[43]
GSM814095
[44]
GSM814096
[45]
GSM814097
[46]
GSM814098
[47]
GSM814099
[48]
GSM814100
[49]
GSM814101
[50]
GSM814102
[51]
GSM814103
[52]
GSM814104
[53]
GSM814105
[54]
GSM814106
[55]
GSM814107
[56]
GSM814108
[57]
GSM814109
[58]
GSM814110
[59]
GSM814111
[60]
GSM814112
[61]
GSM814113
[62]
GSM814114
[63]
GSM814115
[64]
GSM814116
[65]
GSM814117
[66]
GSM814118
[67]
GSM814119
[68]
GSM814120
[69]
GSM814121
[70]
GSM814122
[71]
GSM814123
[72]
GSM814124
[73]
GSM814125
[74]
GSM814126
[75]
GSM814127
[76]
GSM814128
[77]
GSM814129
[78]
GSM814130
[79]
GSM814131
[80]
GSM814132
[81]
GSM814133
[82]
GSM814134
[83]
GSM814135
[84]
GSM814136
[85]
GSM814137
[86]
GSM814138
[87]
GSM814139
[88]
GSM814140
[89]
GSM814141
[90]
GSM814142
[91]
GSM814143
[92]
GSM814144
[93]
GSM814145
[94]
GSM814146
[95]
GSM814147
[96]
GSM814148
[97]
GSM814149
[98]
GSM814150
[99]
GSM814151
[100]
GSM814152
[101]
GSM814153
[102]
GSM814154
[103]
GSM814155
[104]
GSM814156
[105]
GSM814157
[106]
GSM814158
[107]
GSM814159
[108]
GSM814160
[109]
GSM814161
[110]
GSM814162
[111]
GSM814163
[112]
GSM814164
[113]
GSM814165
[114]
GSM814166
[115]
GSM814167
[116]
GSM814168
[117]
GSM814169
[118]
GSM814170
[119]
GSM814171
[120]
GSM814172
[121]
GSM814173
[122]
GSM814174
[123]
GSM814175
[124]
GSM814176
[125]
GSM814177
[126]
GSM814178
[127]
GSM814179
[128]
GSM814180
[129]
GSM814181
[130]
GSM814182
[131]
GSM814183
[132]
GSM814184
[133]
GSM814185
[134]
GSM814186
[135]
GSM814187
[136]
GSM814188
[137]
GSM814189
[138]
GSM814190
[139]
GSM814191
[140]
GSM814192
[141]
GSM814193
[142]
GSM814194
[143]
GSM814195
[144]
GSM814196
[145]
GSM814197
[146]
GSM814198
[147]
GSM814199
[148]
GSM814200
[149]
GSM814201
[150]
GSM814202
[151]
GSM814203
[152]
GSM814204
[153]
GSM814205
[154]
GSM814206
[155]
GSM814207
[156]
GSM814208
[157]
GSM814209
[158]
GSM814210
[159]
GSM814211
[160]
GSM814212
[161]
GSM814213
[162]
GSM814214
[163]
GSM814215
[164]
GSM814216
[165]
GSM814217
[166]
GSM814218
[167]
GSM814219
[168]
GSM814220
[169]
GSM814221
[170]
GSM814222
[171]
GSM814223
[172]
GSM814224
[173]
GSM814225
[174]
GSM814226
[175]
GSM814227
[176]
GSM814228
[177]
GSM814229
[178]
GSM814230
[179]
GSM814231
[180]
GSM814232
[181]
GSM814233
[182]
GSM814234
[183]
GSM814235
[184]
GSM814236
[185]
GSM814237
[186]
GSM814238
[187]
GSM814239
[188]
GSM814240
[189]
GSM814241
[190]
GSM814242
[191]
GSM814243
[192]
GSM814244
[193]
GSM814245
[194]
GSM814246
[195]
GSM814247
[196]
GSM814248
[197]
GSM814249
[198]
GSM814250
[199]
GSM814251
[200]
GSM814252
[201]
GSM814253
[202]
GSM814254
[203]
GSM814255
[204]
GSM814256
[205]
GSM814257
[206]
GSM814258
[207]
GSM814259
[208]
GSM814260
[209]
GSM814261
[210]
GSM814262
[211]
GSM814263
[212]
GSM814264
[213]
GSM814265
[214]
GSM814266
[215]
GSM814267
[216]
GSM814268
[217]
GSM814269
[218]
GSM814270
[219]
GSM814271
[220]
GSM814272
[221]
GSM814273
[222]
GSM814274
[223]
GSM814275
[224]
GSM814276
[225]
GSM814277
[226]
GSM814278
[227]
GSM814279
[228]
GSM814280
[229]
GSM814281
[230]
GSM814282
[231]
GSM814283
[232]
GSM814284
[233]
GSM814285
[234]
GSM814286
[235]
GSM814287
[236]
GSM814288
[237]
GSM814289
[238]
GSM814290
[239]
GSM814291
[240]
GSM814292
[241]
GSM814293
[242]
GSM814294
[243]
GSM814295
[244]
GSM814296
[245]
GSM814297
[246]
GSM814298
[247]
GSM814299
[248]
GSM814300
[249]
GSM814301
[250]
GSM814302
[251]
GSM814303
[252]
GSM814304
[253]
GSM814305
[254]
GSM814306
[255]
GSM814307
[256]
GSM814308
[257]
GSM814309
[258]
GSM814310
[259]
GSM814311
[260]
GSM814312
[261]
GSM814313
[262]
GSM814314
[263]
GSM814315
[264]
GSM814316
[265]
GSM814317
[266]
GSM814318
[267]
GSM814319
[268]
GSM814320
[269]
GSM814321
[270]
GSM814322
[271]
GSM814323
[272]
GSM814324
[273]
GSM814325
[274]
GSM814326
[275]
GSM814327
[276]
GSM814328
[277]
GSM814329
[278]
GSM814330
[279]
GSM814331
[280]
GSM814332
[281]
GSM814333
[282]
GSM814334
[283]
GSM814335
[284]
GSM814336
[285]
GSM814337
[286]
GSM814338
[287]
GSM814339
[288]
GSM814340
[289]
GSM814341
[290]
GSM814342
[291]
GSM814343
[292]
GSM814344
[293]
GSM814345
[294]
GSM814346
[295]
GSM814347
[296]
GSM814348
[297]
GSM814349
[298]
GSM814350
[299]
GSM814351
[300]
GSM814352
[301]
GSM814353
[302]
GSM814354
[303]
GSM814355
[304]
GSM814356
[305]
GSM814357
[306]
GSM814358
[307]
GSM814359
sample_count
308
group_sizes
null
group_sizes_basis
null
platform
6947
taxon
Homo sapiens
title
A Molecular Taxonomy of Urothelial Carcinoma
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:32225123:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:f9c0d78b453303d5c62a112d9ab6af7fea850be09e461b02cb584f637c8a468f
bytes
1449
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[1]#cells-09-00806-t001
version
null
note
Clinicopathological features of 86 patients with pT3 upper tract UC stratified by GAL1 expression.
structure object · 5 fields
pmcid
PMC7226470
section_index
17
section_title
3.2. High Expression of GAL1 is Associated with Poor Disease Recurrence and CSS
row_count
34
column_count
4
table object · 8 fields
label
Table 1
caption
Clinicopathological features of 86 patients with pT3 upper tract UC stratified by GAL1 expression.
rows array · 34 items
[0] array · 4 items
[0]
[1]
GAL1-Low
[2]
GAL1-High
[3]
p-Value
[1] array · 4 items
[0]
[1]
(N = 51, %)
[2]
(N = 35, %)
[3]
[2] array · 4 items
[0]
Age (years)
[1]
70.5 ± 10.8
[2]
68.0 ± 9.8
[3]
0.27
[3] array · 4 items
[0]
Gender
[1]
[2]
[3]
[4] array · 4 items
[0]
Female
[1]
31 (60.8)
[2]
18 (51.4)
[3]
0.39
[5] array · 4 items
[0]
Male
[1]
20 (39.2)
[2]
17 (48.6)
[3]
[6] array · 4 items
[0]
Smoking
[1]
[2]
[3]
[7] array · 4 items
[0]
Yes
[1]
8 (15.7)
[2]
4 (11.4)
[3]
0.75
[8] array · 4 items
[0]
No
[1]
43 (84.3)
[2]
31 (88.6)
[3]
[9] array · 4 items
[0]
Primary site
[1]
[2]
[3]
[10] array · 4 items
[0]
Renal pelvis
[1]
26 (51.0)
[2]
26 (74.3)
[3]
0.09
[11] array · 4 items
[0]
Ureter
[1]
19 (37.3)
[2]
7 (20.1)
[3]
[12] array · 4 items
[0]
Both
[1]
6 (11.8)
[2]
2 (5.7)
[3]
[13] array · 4 items
[0]
Grade
[1]
[2]
[3]
[14] array · 4 items
[0]
Low
[1]
0 (0)
[2]
1 (2.9)
[3]
0.41
[15] array · 4 items
[0]
High
[1]
51 (100)
[2]
34 (97.1)
[3]
[16] array · 4 items
[0]
Histopathologic variant
[1]
[2]
[3]
[17] array · 4 items
[0]
Presence
[1]
20 (39.2)
[2]
14 (40)
[3]
0.94
[18] array · 4 items
[0]
Absence
[1]
31 (60.8)
[2]
21 (60)
[3]
[19] array · 4 items
[0]
CIS
[1]
[2]
[3]
[20] array · 4 items
[0]
Presence
[1]
17 (33.3)
[2]
13 (37.1)
[3]
0.72
[21] array · 4 items
[0]
Absence
[1]
34 (66.7)
[2]
22 (62.9)
[3]
[22] array · 4 items
[0]
LVI
[1]
[2]
[3]
[23] array · 4 items
[0]
Presence
[1]
20 (39.2)
[2]
14 (40)
[3]
0.94
[24] array · 4 items
[0]
Absence
[1]
31 (60.8)
[2]
21 (60)
[3]
[25] array · 4 items
[0]
Tumor necrosis
[1]
[2]
[3]
[26] array · 4 items
[0]
Presence
[1]
18 (35.3)
[2]
16 (45.7)
[3]
0.33
[27] array · 4 items
[0]
Absence
[1]
33 (64.7)
[2]
19 (54.3)
[3]
[28] array · 4 items
[0]
Multicentricity
[1]
[2]
[3]
[29] array · 4 items
[0]
Yes
[1]
12 (23.5)
[2]
5 (14.3)
[3]
0.29
[30] array · 4 items
[0]
No
[1]
39 (76.5)
[2]
30 (85.7)
[3]
[31] array · 4 items
[0]
Papillary feature
[1]
[2]
[3]
[32] array · 4 items
[0]
Presence
[1]
31 (60.8)
[2]
15 (42.9)
[3]
0.10
[33] array · 4 items
[0]
Absence
[1]
20 (39.2)
[2]
20 (57.1)
[3]
locator
section[17]/table-wrap[1]#cells-09-00806-t001
[3] object · 16 fields
id
asset:table:pmid:32225123:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:1becf135f09cfd4d6336668115a8974911aacdda930ac9851ab61d214680925d
bytes
1410
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[17]/table-wrap[2]#cells-09-00806-t002
version
null
note
Univariate and multivariate analyses of RFS and CSS.
structure object · 5 fields
pmcid
PMC7226470
section_index
17
section_title
3.2. High Expression of GAL1 is Associated with Poor Disease Recurrence and CSS
row_count
25
column_count
7
table object · 8 fields
label
Table 2
caption
Univariate and multivariate analyses of RFS and CSS.
rows array · 25 items
[0] array · 3 items
[0]
Characteristics
[1]
RFS
[2]
CSS
[1] array · 4 items
[0]
Univariate
[1]
Multivariate
[2]
Univariate
[3]
Multivariate
[2] array · 6 items
[0]
p-Value
[1]
HR (95% CI)
[2]
p-Value
[3]
p-Value
[4]
HR (95% CI)
[5]
p-Value
[3] array · 7 items
[0]
Age
[1]
[2]
[3]
[4]
[5]
[6]
[4] array · 7 items
[0]
≥65 vs. <65
[1]
0.99
[2]
[3]
[4]
0.67
[5]
[6]
[5] array · 7 items
[0]
Gender
[1]
[2]
[3]
[4]
[5]
[6]
[6] array · 7 items
[0]
Male vs. female
[1]
0.17
[2]
[3]
[4]
0.41
[5]
[6]
[7] array · 7 items
[0]
Smoking history
[1]
[2]
[3]
[4]
[5]
[6]
[8] array · 7 items
[0]
Yes vs. no
[1]
0.16
[2]
[3]
[4]
0.08
[5]
[6]
[9] array · 7 items
[0]
Primary site
[1]
[2]
[3]
[4]
[5]
[6]
[10] array · 7 items
[0]
Kidney vs. ureter
[1]
0.24
[2]
2.03 (0.96–4.28)
[3]
0.06
[4]
0.23
[5]
[6]
[11] array · 7 items
[0]
Histological variant
[1]
[2]
[3]
[4]
[5]
[6]
[12] array · 7 items
[0]
Presence vs. absence
[1]
0.74
[2]
[3]
[4]
0.26
[5]
3.65 (1.20–11.12)
[6]
0.023
[13] array · 7 items
[0]
LVI
[1]
[2]
[3]
[4]
[5]
[6]
[14] array · 7 items
[0]
Presence vs. absence
[1]
0.043
[2]
2.41 (1.15–5.05)
[3]
0.02
[4]
0.18
[5]
3.56 (1.06–11.88)
[6]
0.039
[15] array · 7 items
[0]
Tumor necrosis
[1]
[2]
[3]
[4]
[5]
[6]
[16] array · 7 items
[0]
Presence vs. absence
[1]
0.25
[2]
[3]
[4]
0.35
[5]
[6]
[17] array · 7 items
[0]
CIS
[1]
[2]
[3]
[4]
[5]
[6]
[18] array · 7 items
[0]
Presence vs. absence
[1]
0.97
[2]
[3]
[4]
0.96
[5]
[6]
[19] array · 7 items
[0]
Papillary feature
[1]
[2]
[3]
[4]
[5]
[6]
[20] array · 7 items
[0]
Presence vs. absence
[1]
0.039
[2]
[3]
[4]
0.62
[5]
[6]
[21] array · 7 items
[0]
Multicentricity
[1]
[2]
[3]
[4]
[5]
[6]
[22] array · 7 items
[0]
Yes vs. no
[1]
0.74
[2]
[3]
[4]
0.82
[5]
[6]
[23] array · 7 items
[0]
Galectin-1
[1]
[2]
[3]
[4]
[5]
[6]
[24] array · 7 items
[0]
High vs. low
[1]
0.028
[2]
2.43 (1.17–5.05)
[3]
0.018
[4]
0.025
[5]
4.04 (1.25–13.03)
[6]
0.019
locator
section[17]/table-wrap[2]#cells-09-00806-t002
[4] object · 16 fields
id
asset:table:pmid:32225123:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:2aa5c99b39866a3cf285e50ffaf7228a2bfb7743e36bc3ced764b7715fc831c4
bytes
902
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[26]/table-wrap[1]#array1
version
null
note
null
structure object · 5 fields
pmcid
PMC7226470
section_index
26
section_title
Abbreviations
row_count
20
column_count
2
table object · 8 fields
label
null
caption
null
rows array · 20 items
[0] array · 2 items
[0]
CIS:
[1]
carcinoma in situ;
[1] array · 2 items
[0]
CSS:
[1]
cancer-specific survival;
[2] array · 2 items
[0]
ECM:
[1]
extracellular matrix;
[3] array · 2 items
[0]
EMT:
[1]
epithelial-mesenchymal transition;
[4] array · 2 items
[0]
FAK:
[1]
focal adhesion kinase;
[5] array · 2 items
[0]
GAL1:
[1]
galectin-1;
[6] array · 2 items
[0]
HR:
[1]
hazard ratio;
[7] array · 2 items
[0]
IHC:
[1]
immunohistochemical;
[8] array · 2 items
[0]
IQR:
[1]
interquartile range;
[9] array · 2 items
[0]
LVI:
[1]
lymphovascular invasion;
[10] array · 2 items
[0]
MMP:
[1]
matrix metalloproteinase;
[11] array · 2 items
[0]
mTOR:
[1]
mammalian target of rapamycin;
[12] array · 2 items
[0]
PI3K:
[1]
phosphoinositide 3-kinase;
[13] array · 2 items
[0]
q-PCR:
[1]
quantitative polymerase chain reaction;
[14] array · 2 items
[0]
RFS:
[1]
recurrence-free survival;
[15] array · 2 items
[0]
TCGA:
[1]
The Cancer Genome Atlas;
[16] array · 2 items
[0]
TIMP:
[1]
tissue inhibitors of metalloproteinases;
[17] array · 2 items
[0]
UC:
[1]
urothelial carcinoma;
[18] array · 2 items
[0]
UCB:
[1]
urothelial carcinoma of the bladder;
[19] array · 2 items
[0]
UTUC:
[1]
upper tract urothelial carcinoma.
locator
section[26]/table-wrap[1]#array1
gaps array · 2 items
[0]
asset:data:geo:GSE32894 not downloaded
[1]
asset:data:geo:GSE32894 licence not read
analysis object · 4 fields
state
partial
methods array · 2 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[1] object · 10 fields
id
method-2
family
null
specific
null
label
Kaplan–Meier analyses and Cox proportional regression models
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
Kaplan–Meier analyses and Cox proportional regression models were used for univariate and multivariate survival analyses.
targets array · 0 items
gaps array · 1 item
[0]
method.reader_named_unmapped
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
GSE32894
resolved_accessions array · 1 item
[0]
GSE32894
statements array · 1 item
[0]
We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).
basis
The paper names GSE32894 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
survival_km
assets array · 5 items
[0]
source:pmid:32225123
[1]
data:geo:GSE32894
[2]
asset:table:pmid:32225123:1
[3]
asset:table:pmid:32225123:2
[4]
asset:table:pmid:32225123:3
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE32894
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:19:02Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
null
calls
3
usage object · 3 fields
prompt_tokens
39518
completion_tokens
1941
cached_tokens
13320
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:32225123
type
paper
label
pmid:32225123
[1] object · 3 fields
id
source:pmid:32225123
type
manuscript
label
PMID 32225123 full text
[2] object · 3 fields
id
data:geo:GSE32894
type
dataset
label
GEO GSE32894
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:32225123
type
paper
label
pmid:32225123
[1] object · 3 fields
id
source:pmid:32225123
type
manuscript
label
PMID 32225123 full text
[2] object · 3 fields
id
data:geo:GSE32894
type
dataset
label
GEO GSE32894
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-32225123
type
extraction
used array · 1 item
[0]
source:pmid:32225123
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE32894
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE32894
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:32225123
parent_hash
sha256:0930a2af5f037e8d5f7d7485fe37beb47b79c39247e2b223e9c58df976766c8f
fork_of
null
gaps array · 7 items
[0]
asset:data:geo:GSE32894 licence not read
[1]
asset:data:geo:GSE32894 not downloaded
[2]
execution.not_run
[3]
method.reader_named_unmapped
[4]
review.human_critique
[5]
review.independent_reader
[6]
review.machine_critique
assays array · 5 items
[0] object · 11 fields
role
data_generation
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
ssion models and in GAL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the
[1]
AL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the Cance
[2]
35) and GAL1-low (GAL1 n = 51), according to IHC interpretation. Univariate analysis revealed
[3]
emorial Hospital. 2.12. Statistical Analysis IHC staining of tumor specimens was performed us
order_basis
paper_text_order:762
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
transfection
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
0.019). In vitro studies revealed that GAL1 knockdown significantly reduced migration and invasive
[1]
TC-909) and bladder cancer cells (T24). GAL1 knockdown significantly reduced protein levels of matr
[2]
r and GAL1-KD). (D) Western blotting of GAL1 knockdown or overexpression in the FAK/PI3K/AKT/mTOR s
order_basis
paper_text_order:1706
id
assay:2
[2] object · 11 fields
role
data_generation
definition_id
microarray
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
al transition (EMT). Through gene expression microarray analysis of GAL1 vector and GAL1-KD cells, w
[1]
se/protein kinase B (PI3K/AKT). We validated microarray results through immunoblotting, thus proving
[2]
high-throughput analysis by using Clariom D microarray to analyze two replicate samples (GAL1 vecto
[3]
AKT/mTOR pathway alteration assessed through microarray and Western blotting analyses: (A) A heatmap
order_basis
paper_text_order:2059
id
assay:3
[3] object · 11 fields
role
data_generation
definition_id
western_blot
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
KT). We validated microarray results through immunoblotting, thus proving that downregulation of GAL1 re
[1]
y alteration assessed through microarray and Western blotting analyses: (A) A heatmap revealed upregulatio
[2]
BFTC-909 cells (GAL-vector and GAL1-KD). (D) Western blotting of GAL1 knockdown or overexpression in the F
order_basis
paper_text_order:2304
id
assay:4
[4] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
survival_km
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Kaplan-Meier
order_basis
consumes_earlier_output
id
assay:5
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32225123", "kind": "science-record", "revision": 7, "content_hash": "sha256:f0c0304aff5d9bed5078909a5c3bd9aafb8e704412eb7d879ccb7e4b06bdd0d2", "created_at": "2026-11-01T15:40:58Z", "updated_at": "2026-11-01T21:23:03Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Galectin-1 Overexpression Activates the FAK/PI3K/AKT/mTOR Pathway and Is Correlated with Upper Urinary Urothelial Carcinoma Progression and Survival.", "doi": "10.3390/cells9040806", "pmid": "32225123", "authors": ["Yu-Li Su", "Hao-Lun Luo", "Chun-Chieh Huang", "Ting-Ting Liu", "Eng-Yen Huang", "Ming-Tse Sung", "Jen-Jie Lin", "Po-Hui Chiang", "Yen-Ta Chen", "Chih-Hsiung Kang", "Yuan-Tso Cheng"], "journal": "Cells", "year": 2020, "abstract": "Galectin-1 (GAL1) is a β-galactoside-binding protein involved in multiple aspects of tumorigenesis. However, the biological role of GAL1 in upper tract urothelial carcinoma (UTUC) has not been entirely understood. Herein, we investigated the oncological effects of GAL1 expression in tumor specimens and identified related gene alterations through molecular analysis of GAL1. Clinical parameter data and tumor specimens were collected from 86 patients with pT3N0M0 UTUC who had undergone radical nephroureterectomy. We analyzed the difference in survival by using Kaplan-Meier analyses and Cox proportional regression models and in GAL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the Cancer Genome Atlas (TCGA) and GSE32894 data sets were analyzed for comparison. Using four urothelial carcinoma (UC) cell lines (BFTC-909, T24, RT4, and J82) as in vitro models, we evaluated the functions of GAL1 in UC cell growth, invasiveness, and migration and its role in downstream signaling pathways. The study population was classified into two groups, GAL1-high (n = 35) and GAL1-low (GAL1 n = 51), according to IHC interpretation. Univariate analysis revealed that high GAL1 expression was significantly associated with poor recurrence-free survival (RFS; p = 0.028) and low cancer-specific survival (CSS; p = 0.025). Multivariate analysis revealed that GAL1-high was an independent predictive factor for RFS (hazard ratio (HR) 2.43; 95% confidence interval (CI) 1.17-5.05, p = 0.018) and CSS (HR 4.04; 95% CI 1.25-13.03, p = 0.019). In vitro studies revealed that GAL1 knockdown significantly reduced migration and invasiveness in UTUC (BFTC-909) and bladder cancer cells (T24). GAL1 knockdown significantly reduced protein levels of matrix metalloproteinase-2 (MMP-2) and MMP-9, which increased tissue inhibitor of metalloproteinase-1 (TIMP-1) and promoted epithelial-mesenchymal transition (EMT). Through gene expression microarray analysis of GAL1 vector and GAL1-KD cells, we identified multiple significant signaling pathways including p53, Forkhead box O (FOXO), and phosphoinositide 3-kinase/protein kinase B (PI3K/AKT). We validated microarray results through immunoblotting, thus proving that downregulation of GAL1 reduced focal adhesion kinase (FAK), p-PI3K, p-AKT, and p-mTOR expression. We concluded that GAL1 expression was highly related to oncological survival in patients with locally advanced UTUC. GAL1 promoted UC invasion and metastasis by activating the FAK/PI3K/AKT/mTOR pathway.", "claims": [{"id": "claim-method", "statement": "Kaplan–Meier analyses and Cox proportional regression models were used for univariate and multivariate survival analyses.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32225123", "locator": "sections[14] \"2.12. Statistical Analysis\" paragraph 2", "quote": "Kaplan–Meier analyses and Cox proportional regression models were used for univariate and multivariate survival analyses."}], "state": "complete"}, {"id": "claim-data-access", "statement": "We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32225123", "locator": "sections[13] \"2.11. Bioinformatics Analysis\" paragraph 2", "quote": "We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32225123"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE32894"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE32894"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32225123", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3390/cells9040806", "sha256": "sha256:6e01640ca0b329a9380c87ac0efde3ca904f3c66844242c2cb268ffc2564046e", "bytes": 46843, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3390/cells9040806", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7226470", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE32894", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32894", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE32894", "version": null, "note": "We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html).", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM814052", "GSM814053", "GSM814054", "GSM814055", "GSM814056", "GSM814057", "GSM814058", "GSM814059", "GSM814060", "GSM814061", "GSM814062", "GSM814063", "GSM814064", "GSM814065", "GSM814066", "GSM814067", "GSM814068", "GSM814069", "GSM814070", "GSM814071", "GSM814072", "GSM814073", "GSM814074", "GSM814075", "GSM814076", "GSM814077", "GSM814078", "GSM814079", "GSM814080", "GSM814081", "GSM814082", "GSM814083", "GSM814084", "GSM814085", "GSM814086", "GSM814087", "GSM814088", "GSM814089", "GSM814090", "GSM814091", "GSM814092", "GSM814093", "GSM814094", "GSM814095", "GSM814096", "GSM814097", "GSM814098", "GSM814099", "GSM814100", "GSM814101", "GSM814102", "GSM814103", "GSM814104", "GSM814105", "GSM814106", "GSM814107", "GSM814108", "GSM814109", "GSM814110", "GSM814111", "GSM814112", "GSM814113", "GSM814114", "GSM814115", "GSM814116", "GSM814117", "GSM814118", "GSM814119", "GSM814120", "GSM814121", "GSM814122", "GSM814123", "GSM814124", "GSM814125", "GSM814126", "GSM814127", "GSM814128", "GSM814129", "GSM814130", "GSM814131", "GSM814132", "GSM814133", "GSM814134", "GSM814135", "GSM814136", "GSM814137", "GSM814138", "GSM814139", "GSM814140", "GSM814141", "GSM814142", "GSM814143", "GSM814144", "GSM814145", "GSM814146", "GSM814147", "GSM814148", "GSM814149", "GSM814150", "GSM814151", "GSM814152", "GSM814153", "GSM814154", "GSM814155", "GSM814156", "GSM814157", "GSM814158", "GSM814159", "GSM814160", "GSM814161", "GSM814162", "GSM814163", "GSM814164", "GSM814165", "GSM814166", "GSM814167", "GSM814168", "GSM814169", "GSM814170", "GSM814171", "GSM814172", "GSM814173", "GSM814174", "GSM814175", "GSM814176", "GSM814177", "GSM814178", "GSM814179", "GSM814180", "GSM814181", "GSM814182", "GSM814183", "GSM814184", "GSM814185", "GSM814186", "GSM814187", "GSM814188", "GSM814189", "GSM814190", "GSM814191", "GSM814192", "GSM814193", "GSM814194", "GSM814195", "GSM814196", "GSM814197", "GSM814198", "GSM814199", "GSM814200", "GSM814201", "GSM814202", "GSM814203", "GSM814204", "GSM814205", "GSM814206", "GSM814207", "GSM814208", "GSM814209", "GSM814210", "GSM814211", "GSM814212", "GSM814213", "GSM814214", "GSM814215", "GSM814216", "GSM814217", "GSM814218", "GSM814219", "GSM814220", "GSM814221", "GSM814222", "GSM814223", "GSM814224", "GSM814225", "GSM814226", "GSM814227", "GSM814228", "GSM814229", "GSM814230", "GSM814231", "GSM814232", "GSM814233", "GSM814234", "GSM814235", "GSM814236", "GSM814237", "GSM814238", "GSM814239", "GSM814240", "GSM814241", "GSM814242", "GSM814243", "GSM814244", "GSM814245", "GSM814246", "GSM814247", "GSM814248", "GSM814249", "GSM814250", "GSM814251", "GSM814252", "GSM814253", "GSM814254", "GSM814255", "GSM814256", "GSM814257", "GSM814258", "GSM814259", "GSM814260", "GSM814261", "GSM814262", "GSM814263", "GSM814264", "GSM814265", "GSM814266", "GSM814267", "GSM814268", "GSM814269", "GSM814270", "GSM814271", "GSM814272", "GSM814273", "GSM814274", "GSM814275", "GSM814276", "GSM814277", "GSM814278", "GSM814279", "GSM814280", "GSM814281", "GSM814282", "GSM814283", "GSM814284", "GSM814285", "GSM814286", "GSM814287", "GSM814288", "GSM814289", "GSM814290", "GSM814291", "GSM814292", "GSM814293", "GSM814294", "GSM814295", "GSM814296", "GSM814297", "GSM814298", "GSM814299", "GSM814300", "GSM814301", "GSM814302", "GSM814303", "GSM814304", "GSM814305", "GSM814306", "GSM814307", "GSM814308", "GSM814309", "GSM814310", "GSM814311", "GSM814312", "GSM814313", "GSM814314", "GSM814315", "GSM814316", "GSM814317", "GSM814318", "GSM814319", "GSM814320", "GSM814321", "GSM814322", "GSM814323", "GSM814324", "GSM814325", "GSM814326", "GSM814327", "GSM814328", "GSM814329", "GSM814330", "GSM814331", "GSM814332", "GSM814333", "GSM814334", "GSM814335", "GSM814336", "GSM814337", "GSM814338", "GSM814339", "GSM814340", "GSM814341", "GSM814342", "GSM814343", "GSM814344", "GSM814345", "GSM814346", "GSM814347", "GSM814348", "GSM814349", "GSM814350", "GSM814351", "GSM814352", "GSM814353", "GSM814354", "GSM814355", "GSM814356", "GSM814357", "GSM814358", "GSM814359"], "sample_count": 308, "group_sizes": null, "group_sizes_basis": null, "platform": "6947", "taxon": "Homo sapiens", "title": "A Molecular Taxonomy of Urothelial Carcinoma", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32225123:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:f9c0d78b453303d5c62a112d9ab6af7fea850be09e461b02cb584f637c8a468f", "bytes": 1449, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[1]#cells-09-00806-t001", "version": null, "note": "Clinicopathological features of 86 patients with pT3 upper tract UC stratified by GAL1 expression.", "structure": {"pmcid": "PMC7226470", "section_index": 17, "section_title": "3.2. High Expression of GAL1 is Associated with Poor Disease Recurrence and CSS", "row_count": 34, "column_count": 4}, "table": {"label": "Table 1", "caption": "Clinicopathological features of 86 patients with pT3 upper tract UC stratified by GAL1 expression.", "rows": [["", "GAL1-Low", "GAL1-High", "p-Value"], ["", "(N = 51, %)", "(N = 35, %)", ""], ["Age (years)", "70.5 ± 10.8", "68.0 ± 9.8", "0.27"], ["Gender", "", "", ""], ["Female", "31 (60.8)", "18 (51.4)", "0.39"], ["Male", "20 (39.2)", "17 (48.6)", ""], ["Smoking", "", "", ""], ["Yes", "8 (15.7)", "4 (11.4)", "0.75"], ["No", "43 (84.3)", "31 (88.6)", ""], ["Primary site", "", "", ""], ["Renal pelvis", "26 (51.0)", "26 (74.3)", "0.09"], ["Ureter", "19 (37.3)", "7 (20.1)", ""], ["Both", "6 (11.8)", "2 (5.7)", ""], ["Grade", "", "", ""], ["Low", "0 (0)", "1 (2.9)", "0.41"], ["High", "51 (100)", "34 (97.1)", ""], ["Histopathologic variant", "", "", ""], ["Presence", "20 (39.2)", "14 (40)", "0.94"], ["Absence", "31 (60.8)", "21 (60)", ""], ["CIS", "", "", ""], ["Presence", "17 (33.3)", "13 (37.1)", "0.72"], ["Absence", "34 (66.7)", "22 (62.9)", ""], ["LVI", "", "", ""], ["Presence", "20 (39.2)", "14 (40)", "0.94"], ["Absence", "31 (60.8)", "21 (60)", ""], ["Tumor necrosis", "", "", ""], ["Presence", "18 (35.3)", "16 (45.7)", "0.33"], ["Absence", "33 (64.7)", "19 (54.3)", ""], ["Multicentricity", "", "", ""], ["Yes", "12 (23.5)", "5 (14.3)", "0.29"], ["No", "39 (76.5)", "30 (85.7)", ""], ["Papillary feature", "", "", ""], ["Presence", "31 (60.8)", "15 (42.9)", "0.10"], ["Absence", "20 (39.2)", "20 (57.1)", ""]], "row_count": 34, "column_count": 4, "numeric_cells": 57, "header_rows": 2, "locator": "section[17]/table-wrap[1]#cells-09-00806-t001"}}, {"id": "asset:table:pmid:32225123:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:1becf135f09cfd4d6336668115a8974911aacdda930ac9851ab61d214680925d", "bytes": 1410, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[17]/table-wrap[2]#cells-09-00806-t002", "version": null, "note": "Univariate and multivariate analyses of RFS and CSS.", "structure": {"pmcid": "PMC7226470", "section_index": 17, "section_title": "3.2. High Expression of GAL1 is Associated with Poor Disease Recurrence and CSS", "row_count": 25, "column_count": 7}, "table": {"label": "Table 2", "caption": "Univariate and multivariate analyses of RFS and CSS.", "rows": [["Characteristics", "RFS", "CSS"], ["Univariate", "Multivariate", "Univariate", "Multivariate"], ["p-Value", "HR (95% CI)", "p-Value", "p-Value", "HR (95% CI)", "p-Value"], ["Age", "", "", "", "", "", ""], ["≥65 vs. <65", "0.99", "", "", "0.67", "", ""], ["Gender", "", "", "", "", "", ""], ["Male vs. female", "0.17", "", "", "0.41", "", ""], ["Smoking history", "", "", "", "", "", ""], ["Yes vs. no", "0.16", "", "", "0.08", "", ""], ["Primary site", "", "", "", "", "", ""], ["Kidney vs. ureter", "0.24", "2.03 (0.96–4.28)", "0.06", "0.23", "", ""], ["Histological variant", "", "", "", "", "", ""], ["Presence vs. absence", "0.74", "", "", "0.26", "3.65 (1.20–11.12)", "0.023"], ["LVI", "", "", "", "", "", ""], ["Presence vs. absence", "0.043", "2.41 (1.15–5.05)", "0.02", "0.18", "3.56 (1.06–11.88)", "0.039"], ["Tumor necrosis", "", "", "", "", "", ""], ["Presence vs. absence", "0.25", "", "", "0.35", "", ""], ["CIS", "", "", "", "", "", ""], ["Presence vs. absence", "0.97", "", "", "0.96", "", ""], ["Papillary feature", "", "", "", "", "", ""], ["Presence vs. absence", "0.039", "", "", "0.62", "", ""], ["Multicentricity", "", "", "", "", "", ""], ["Yes vs. no", "0.74", "", "", "0.82", "", ""], ["Galectin-1", "", "", "", "", "", ""], ["High vs. low", "0.028", "2.43 (1.17–5.05)", "0.018", "0.025", "4.04 (1.25–13.03)", "0.019"]], "row_count": 25, "column_count": 7, "numeric_cells": 38, "header_rows": 3, "locator": "section[17]/table-wrap[2]#cells-09-00806-t002"}}, {"id": "asset:table:pmid:32225123:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:2aa5c99b39866a3cf285e50ffaf7228a2bfb7743e36bc3ced764b7715fc831c4", "bytes": 902, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[26]/table-wrap[1]#array1", "version": null, "note": null, "structure": {"pmcid": "PMC7226470", "section_index": 26, "section_title": "Abbreviations", "row_count": 20, "column_count": 2}, "table": {"label": null, "caption": null, "rows": [["CIS:", "carcinoma in situ;"], ["CSS:", "cancer-specific survival;"], ["ECM:", "extracellular matrix;"], ["EMT:", "epithelial-mesenchymal transition;"], ["FAK:", "focal adhesion kinase;"], ["GAL1:", "galectin-1;"], ["HR:", "hazard ratio;"], ["IHC:", "immunohistochemical;"], ["IQR:", "interquartile range;"], ["LVI:", "lymphovascular invasion;"], ["MMP:", "matrix metalloproteinase;"], ["mTOR:", "mammalian target of rapamycin;"], ["PI3K:", "phosphoinositide 3-kinase;"], ["q-PCR:", "quantitative polymerase chain reaction;"], ["RFS:", "recurrence-free survival;"], ["TCGA:", "The Cancer Genome Atlas;"], ["TIMP:", "tissue inhibitors of metalloproteinases;"], ["UC:", "urothelial carcinoma;"], ["UCB:", "urothelial carcinoma of the bladder;"], ["UTUC:", "upper tract urothelial carcinoma."]], "row_count": 20, "column_count": 2, "numeric_cells": 2, "header_rows": 0, "locator": "section[26]/table-wrap[1]#array1"}}], "gaps": ["asset:data:geo:GSE32894 not downloaded", "asset:data:geo:GSE32894 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-2", "family": null, "specific": null, "label": "Kaplan–Meier analyses and Cox proportional regression models", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Kaplan–Meier analyses and Cox proportional regression models were used for univariate and multivariate survival analyses."}}], "targets": [], "gaps": ["method.reader_named_unmapped"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["survival_km"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE32894"], "resolved_accessions": ["GSE32894"], "statements": ["We analyzed comprehensive TCGA cancer genome expression data by using UALCAN platform (http://ualcan.path.uab.edu/index.html)."], "basis": "The paper names GSE32894 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["survival_km"], "assets": ["source:pmid:32225123", "data:geo:GSE32894", "asset:table:pmid:32225123:1", "asset:table:pmid:32225123:2", "asset:table:pmid:32225123:3"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE32894"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:19:02Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 3, "usage": {"prompt_tokens": 39518, "completion_tokens": 1941, "cached_tokens": 13320}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32225123", "type": "paper", "label": "pmid:32225123"}, {"id": "source:pmid:32225123", "type": "manuscript", "label": "PMID 32225123 full text"}, {"id": "data:geo:GSE32894", "type": "dataset", "label": "GEO GSE32894"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32225123", "type": "paper", "label": "pmid:32225123"}, {"id": "source:pmid:32225123", "type": "manuscript", "label": "PMID 32225123 full text"}, {"id": "data:geo:GSE32894", "type": "dataset", "label": "GEO GSE32894"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32225123", "type": "extraction", "used": ["source:pmid:32225123"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE32894", "type": "accession_resolution", "used": ["data:geo:GSE32894"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32225123", "parent_hash": "sha256:0930a2af5f037e8d5f7d7485fe37beb47b79c39247e2b223e9c58df976766c8f", "fork_of": null, "generation": 6}, "gaps": ["asset:data:geo:GSE32894 licence not read", "asset:data:geo:GSE32894 not downloaded", "execution.not_run", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "ihc", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["ssion models and in GAL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the", "AL1 expression by using immunohistochemical (IHC) methods. Public genomic data from the Cance", "35) and GAL1-low (GAL1 n = 51), according to IHC interpretation. Univariate analysis revealed", "emorial Hospital. 2.12. Statistical Analysis IHC staining of tumor specimens was performed us"], "order_basis": "paper_text_order:762", "id": "assay:1"}, {"role": "data_generation", "definition_id": "transfection", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["0.019). In vitro studies revealed that GAL1 knockdown significantly reduced migration and invasive", "TC-909) and bladder cancer cells (T24). GAL1 knockdown significantly reduced protein levels of matr", "r and GAL1-KD). (D) Western blotting of GAL1 knockdown or overexpression in the FAK/PI3K/AKT/mTOR s"], "order_basis": "paper_text_order:1706", "id": "assay:2"}, {"role": "data_generation", "definition_id": "microarray", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["al transition (EMT). Through gene expression microarray analysis of GAL1 vector and GAL1-KD cells, w", "se/protein kinase B (PI3K/AKT). We validated microarray results through immunoblotting, thus proving", "high-throughput analysis by using Clariom D microarray to analyze two replicate samples (GAL1 vecto", "AKT/mTOR pathway alteration assessed through microarray and Western blotting analyses: (A) A heatmap"], "order_basis": "paper_text_order:2059", "id": "assay:3"}, {"role": "data_generation", "definition_id": "western_blot", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["KT). We validated microarray results through immunoblotting, thus proving that downregulation of GAL1 re", "y alteration assessed through microarray and Western blotting analyses: (A) A heatmap revealed upregulatio", "BFTC-909 cells (GAL-vector and GAL1-KD). (D) Western blotting of GAL1 knockdown or overexpression in the F"], "order_basis": "paper_text_order:2304", "id": "assay:4"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["survival_km"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.7, "evidence": ["Kaplan-Meier"], "order_basis": "consumes_earlier_output", "id": "assay:5"}]}